USP9X expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.956400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.830000E-01
Normal-vs-Stage2
6.130800E-01
Normal-vs-Stage3
5.660200E-02
Normal-vs-Stage4
7.909400E-01
Stage1-vs-Stage2
4.611600E-01
Stage1-vs-Stage3
1.878260E-02
Stage1-vs-Stage4
7.121000E-01
Stage2-vs-Stage3
1.333220E-01
Stage2-vs-Stage4
2.674200E-01
Stage3-vs-Stage4
1.560830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.247000E-01
Normal-vs-AfricanAmerican
4.298600E-01
Normal-vs-Asian
3.786800E-01
Caucasian-vs-AfricanAmerican
1.215750E-02
Caucasian-vs-Asian
4.420600E-01
AfricanAmerican-vs-Asian
4.232300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.887600E-01
Normal-vs-Female
8.667400E-01
Male-vs-Female
1.432100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.838600E-01
Normal-vs-Age(41-60Yrs)
9.850000E-01
Normal-vs-Age(61-80Yrs)
4.714000E-01
Normal-vs-Age(81-100Yrs)
1.531160E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.506400E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.547440E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.723800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.549560E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.926000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.377600E-01
Normal-vs-Daily Drinker
3.335200E-01
Normal-vs-Weekly Drinker
3.296000E-01
Normal-vs-Occasional Drinker
7.716200E-01
Normal-vs-Social Drinker
9.986400E-01
Non Drinker-vs-Daily Drinker
9.528400E-01
Non Drinker-vs-Weekly Drinker
7.675000E-01
Non Drinker-vs-Occasional Drinker
1.293250E-01
Non Drinker-vs-Social Drinker
5.115500E-02
Daily Drinker-vs-Weekly Drinker
8.383000E-01
Daily Drinker-vs-Occasional Drinker
2.103800E-01
Daily Drinker-vs-Social Drinker
1.031610E-01
Weekly Drinker-vs-Occasional Drinker
3.189200E-01
Weekly Drinker-vs-Social Drinker
1.713250E-01
Occasional Drinker-vs-Social Drinker
6.296600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.993170E-01
Normal-vs-Grade 2
7.654400E-02
Normal-vs-Grade 3
4.141600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.379600E-01
Grade 1-vs-Grade 3
2.527600E-01
Grade 1-vs-Grade 4
1.993170E-01
Grade 2-vs-Grade 3
3.026400E-01
Grade 2-vs-Grade 4
7.654400E-02
Grade 3-vs-Grade 4
4.141600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.420000E-01
Normal-vs-NonDiabetic
5.157800E-01
Diabetic-vs-NonDiabetic
2.571400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.346400E-01
Normal-vs-NoPancreatitis
4.631400E-01
Pancreatitis-vs-NoPancreatitis
7.175400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.406200E-01
Normal-vs-N1
6.442800E-01
N0-vs-N1
5.499400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.385000E-01
Normal-vs-TP53-NonMutant
7.987000E-01
TP53-Mutant-vs-TP53-NonMutant
5.364800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
